Tanzania

Reimbursed Care Access

Tanzania maintains a strict national drug-control regime (administered through the Drug Control and Enforcement Authority and national drug-control laws) that prohibits recreational possession and trafficking of classical psychedelics while permitting licensed medical use of established anesthetic agents such as ketamine within health facilities. Most classical serotonergic and entheogenic compounds (psilocybin, MDMA, DMT, 5‑MeO‑DMT, mescaline, ibogaine, ayahuasca and novel phenethylamines such as 2C‑X) are treated as controlled/illegal under domestic drug-control legislation with no routine medical reimbursement pathways; access is effectively limited to authorized research or is illegal. Regulatory oversight for medicines, imports and clinical trials is performed by the Tanzania Medicines and Medical Devices Authority (TMDA) while operational enforcement and scheduling is governed by the Drug Control and Enforcement Authority (DCEA) under national drug-control Acts. [https://www.tanzlii.org/akn/tz/act/2015/5/eng|Drug Control and Enforcement Act] [https://tmda.go.tz/|TMDA] [https://www.dcea.go.tz/pages/who-we-are|DCEA].